Breakthrough Studies Reveal Microgravity's Impact on Human Health and Space Medicine Advancements

October 30, 2024
Breakthrough Studies Reveal Microgravity's Impact on Human Health and Space Medicine Advancements
  • Recent research has highlighted the impact of microgravity on human health, with Marotta et al. examining iPSC-derived neural organoids aboard the International Space Station, and their findings published on October 23, 2024.

  • In a related study, Qaisar et al. focused on using mesenchymal stem cell transplants to combat muscle atrophy in simulated microgravity, with their results appearing in Acta Astronautica on October 24, 2024.

  • These studies are part of a broader array of scientific papers supported by NASA, showcasing advancements in spaceflight-related biology and medicine.

  • Cheng et al. provided a comprehensive review of space life sciences, summarizing key topics in the field, which was published in Life Sciences in Space Research on October 21, 2024.

  • Doarn traced the evolution of space medicine at NASA, offering insights into how the field has developed over time, with findings published in Aerospace Medicine and Human Performance on October 9, 2024.

  • Khune et al. conducted a systematic review of physiological responses to space travel, contributing to the understanding of health challenges faced by astronauts, published in the European Journal of Cardiovascular Medicine on October 14, 2024.

  • Linhardt et al. discussed the potential of autonomous agents to enhance well-being and teamwork in space environments, with their work published in Acta Astronautica on October 18, 2024.

  • Lazow et al. reviewed the application of percutaneous cholecystostomy for treating acute cholecystitis during spaceflight, emphasizing the importance of medical procedures in space, published in Aerospace Medicine and Human Performance in October 2024.

  • Tran et al. studied the effects of cosmic-ray radiation on ibuprofen tablet formulations in space, highlighting the challenges of maintaining medication efficacy in extraterrestrial environments, with results published on October 23, 2024.

  • Velarde et al. explored molecular determinants of skeletal muscle force loss due to dry immersion, contributing to the understanding of muscle atrophy in microgravity, published in the Journal of Cachexia, Sarcopenia and Muscle on October 25, 2024.

  • Lastly, Suwanprakorn et al. conducted a transcriptomic analysis of mouse hypothalamic cells under simulated space conditions, with their findings published on October 30, 2024, furthering insights into the biological impacts of space travel.

Summary based on 1 source


Get a daily email with more Science stories

More Stories